RIVAROXABAN HAS DEMONSTRATED AN ADVANTAGE OVER ACETYLSALICYLIC ACID IN PREVENTING THE RECURRENCE OF VENOUS THROMBOEMBOLIC EVENTS IN THE EINSTEIN CHOICE STUDY
Press Release of Bayer AG
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
Столичная издательская компания,
2017-05-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Press Release of Bayer AG |
|---|---|
| Item Description: | 1819-6446 2225-3653 |